Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Myocet/Lapatinib Study. ICORG 10-03, V5

This study has been terminated.
(Slower than anticipated accrual)
Information provided by (Responsible Party):
Cancer Trials Ireland Identifier:
First received: December 16, 2011
Last updated: October 23, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)